|Purification||Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant.|
|Shelf Life||18 months from date of despatch.|
|Target/Specificity||Mouse anti-Rabbit CD8 antibody, clone 12.C7 recognizes the rabbit CD8 cell surface antigen, expressed by a subset of T lymphocytes with cytotoxic/suppressor activity.|
|Preservative & Stabilisers||0.09% Sodium Azide (NaN3); 1% Bovine Serum Albumin|
|Storage||Store at +4℃ or -20℃.|
|Precautions||Anti-Rabbit CD8 Antibody, clone 12.C7 (FITC) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1. De Smet, W. et al. (1983) Rabbit leukocyte surface antigens defined by monoclonal antibodies.Eur J Immunol. 13: 919-28. 2. Dewals, B. et al. (2008) Malignant catarrhal fever induced by alcelaphine herpesvirus 1 is associated with proliferation of CD8+ T cells supporting a latent infection.PLos ONE 3: e1627. 3. Zhao, L. et al. (2011) Evaluation of immunocompatibility of tissue-engineered periosteum.Biomed Mater.6:015005. 4. Wilkinson, J.M. et al. (1992) A cytotoxic rabbit T-cell line infected with a gamma-herpes virus which expresses CD8 and class II antigens.Immunology. 77: 106-8. 5. Marques, R.M. et al. (2012) Early inflammatory response of young rabbits attending natural resistance to calicivirus (RHDV) infection.Vet Immunol Immunopathol. 150: 181-8. 6. Schock, A. and Reid, H.W. (1996) Characterisation of the lymphoproliferation in rabbits experimentally affected with malignant catarrhal fever.Vet Microbiol. 53: 111-9. 7. Beghelli, D. et al. (2012) Phytoderivates in Rabbit Diet and Immune responses.Proceedings 10th World Rabbit Congress: 1019-23 8. Khan, A.A. et al. (2015) Therapeutic Immunization with a Mixture of Herpes Simplex Virus Type 1 Glycoprotein D Derived"Asymptomatic"Human CD8+ T-cell Epitopes Decreases Spontaneous Ocular Shedding in Latently Infected HLA Transgenic Rabbits: Association with Low Frequency of Local PD-1+TIM-3+CD8+ Exhausted T Cells.J Virol. pii: JVI.00788-15. 9. Srivastava, R. et al. (2015) A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a"Humanized"HLA Transgenic Rabbit Model.Invest Ophthalmol Vis Sci. 56 (6): 4013-28. 10. Hanson, N.B. & Lanning, D.K. (2008) Microbial induction of B and T cell areas in rabbit appendix.Dev Comp Immunol. 32 (8): 980-91. 11. Waclavicek, M. et al. (2009) Analysis of the early response to TSST-1 reveals Vbeta-unrestricted extravasation, compartmentalization of the response, and unresponsiveness but not anergy to TSST-1.J Leukoc Biol. 85 (1): 44-54. 13. Dewals, B. et al.(2011)Ex vivo bioluminescence detection of alcelaphine herpesvirus 1 infection during malignant catarrhal fever.J Virol. 85 (14): 6941-54. 14. Anderson, I.E. et al. (2008) Production and utilization of interleukin-15 in malignant catarrhal fever.J Comp Pathol. 138 (2-3): 131-44. 15. Stich N et al. (2010) Staphylococcal superantigen (TSST-1) mutant analysis reveals that t cell activation is required for biological effects in the rabbit including the cytokine storm.Toxins (Basel). 2 (9): 2272-88. 16. Myster, F. et al. (2015) Viral semaphorin inhibits dendritic cell phagocytosis and migration but is not essential for gammaherpesvirus-induced lymphoproliferation in malignant catarrhal fever.J Virol. 89 (7): 3630-47.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.